JP2009513692A5 - - Google Patents

Download PDF

Info

Publication number
JP2009513692A5
JP2009513692A5 JP2008538400A JP2008538400A JP2009513692A5 JP 2009513692 A5 JP2009513692 A5 JP 2009513692A5 JP 2008538400 A JP2008538400 A JP 2008538400A JP 2008538400 A JP2008538400 A JP 2008538400A JP 2009513692 A5 JP2009513692 A5 JP 2009513692A5
Authority
JP
Japan
Prior art keywords
provisos
lipoxygenase
inhibition
diseases
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2008538400A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009513692A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/GB2006/004042 external-priority patent/WO2007052000A1/en
Publication of JP2009513692A publication Critical patent/JP2009513692A/ja
Publication of JP2009513692A5 publication Critical patent/JP2009513692A5/ja
Withdrawn legal-status Critical Current

Links

JP2008538400A 2005-11-01 2006-10-30 炎症の治療に有用なピラゾール化合物 Withdrawn JP2009513692A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US73192805P 2005-11-01 2005-11-01
PCT/GB2006/004042 WO2007052000A1 (en) 2005-11-01 2006-10-30 Pyrazoles useful in the treatment of inflammation

Publications (2)

Publication Number Publication Date
JP2009513692A JP2009513692A (ja) 2009-04-02
JP2009513692A5 true JP2009513692A5 (enExample) 2009-12-17

Family

ID=36572265

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008538400A Withdrawn JP2009513692A (ja) 2005-11-01 2006-10-30 炎症の治療に有用なピラゾール化合物

Country Status (4)

Country Link
US (1) US20090088463A1 (enExample)
EP (1) EP1943225A1 (enExample)
JP (1) JP2009513692A (enExample)
WO (1) WO2007052000A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006032851A1 (en) * 2004-09-20 2006-03-30 Biolipox Ab Pyrazole compounds useful in the treatment of inflammation
TW200800911A (en) * 2005-10-20 2008-01-01 Biolipox Ab Pyrazoles useful in the treatment of inflammation
TW200732320A (en) * 2005-10-31 2007-09-01 Biolipox Ab Pyrazoles useful in the treatment of inflammation
EA200801108A1 (ru) * 2005-10-31 2008-10-30 Биолипокс Аб Триазолы, пригодные для лечения воспалений

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1306260C (en) * 1985-10-18 1992-08-11 Shionogi & Co., Ltd. Condensed imidazopyridine derivatives
US5258397A (en) * 1988-11-30 1993-11-02 Novapharme 3-Isoxazoyl derivatives endowed with anticonvulsant activity, procedure for their preparation and their pharmaceutical compositions
FR2639636B1 (fr) * 1988-11-30 1994-03-04 Novapharme Nouveaux composes heterocycliques a activite anticonvulsivante, procede de preparation et compositions therapeutiques les contenant
US5464860A (en) * 1988-11-30 1995-11-07 Novapharme N(pyrazol-3-yl) benzamides and pharmaceutical compositions
AU668180B2 (en) * 1992-05-20 1996-04-26 Merck & Co., Inc. 17-ethers and thioethers of 4-aza-steroids
CA2135173A1 (en) * 1992-05-20 1993-11-25 Bruce E. Witzel Ester derivatives of 4-aza-steroids
US5665737B1 (en) * 1994-10-12 1999-02-16 Euro Celtique Sa Substituted benzoxazoles
US6372770B1 (en) * 1994-10-12 2002-04-16 Euro-Celtique, S.A. Benzoxazoles
US5663357A (en) * 1995-11-22 1997-09-02 Allergan Substituted heteroarylamides having retinoid-like biological activity
GB9603095D0 (en) * 1996-02-14 1996-04-10 Zeneca Ltd Quinazoline derivatives
AU778393B2 (en) * 1999-05-12 2004-12-02 Ortho-Mcneil Pharmaceutical, Inc. Pyrazole carboxamides useful for the treatment of obesity and other disorders
US6632815B2 (en) * 1999-09-17 2003-10-14 Millennium Pharmaceuticals, Inc. Inhibitors of factor Xa
US7393842B2 (en) * 2001-08-31 2008-07-01 University Of Connecticut Pyrazole analogs acting on cannabinoid receptors
GB0002666D0 (en) * 2000-02-04 2000-03-29 Univ London Blockade of voltage dependent sodium channels
AU2001234958A1 (en) * 2000-02-11 2001-08-20 Bristol-Myers Squibb Company Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators for treating respiratory and non-respiratory diseases
GB0011094D0 (en) * 2000-05-08 2000-06-28 Black James Foundation Gastrin and cholecystokinin receptor ligands (III)
US20040043904A1 (en) * 2000-09-22 2004-03-04 Hiroshi Yamaguchi N-(4-pyrazolyl) amide derivatives, chemicals for agricultural and horticultural use, and usage of the same
JP4465133B2 (ja) * 2001-02-08 2010-05-19 クミアイ化学工業株式会社 イソオキサゾリン誘導体及びこれを有効成分とする除草剤
DE10110750A1 (de) * 2001-03-07 2002-09-12 Bayer Ag Neuartige Aminodicarbonsäurederivate mit pharmazeutischen Eigenschaften
DE60235114D1 (de) * 2001-11-01 2010-03-04 Icagen Inc Pyrazolamide zur anwendung in der behandlung von schmerz
TWI263497B (en) * 2002-03-29 2006-10-11 Lilly Co Eli Pyridinoylpiperidines as 5-HT1F agonists
WO2004039795A2 (en) * 2002-10-29 2004-05-13 Fujisawa Pharmaceutical Co., Ltd. Amide compounds for the treatment of hyperlipidemia
EP2172460A1 (en) * 2002-11-01 2010-04-07 Vertex Pharmaceuticals Incorporated Compositions useful as inhibitors of JAK and other protein kinases
US7382703B2 (en) * 2002-12-13 2008-06-03 Matsushita Electric Industrial Co., Ltd. Optical disc apparatus
US7429581B2 (en) * 2002-12-23 2008-09-30 Sanofi-Aventis Deutschland Gmbh Pyrazole-derivatives as factor Xa inhibitors
JP2006520373A (ja) * 2003-03-14 2006-09-07 バイオリポックス エービー 炎症の治療に有用なピラゾール化合物
SE0300705D0 (sv) * 2003-03-14 2003-03-14 Biolipox Ab New compounds
WO2004096795A2 (en) * 2003-04-25 2004-11-11 3-Dimensional Pharmaceuticals, Inc. C-fms kinase inhibitors
GB0312609D0 (en) * 2003-06-02 2003-07-09 Astrazeneca Ab Novel compounds
US20080090836A1 (en) * 2004-09-20 2008-04-17 Peter Nilsson Pyrazole Compounds Useful In The Treatment Of Inflammation
TW200800911A (en) * 2005-10-20 2008-01-01 Biolipox Ab Pyrazoles useful in the treatment of inflammation
TW200732320A (en) * 2005-10-31 2007-09-01 Biolipox Ab Pyrazoles useful in the treatment of inflammation
EA200801108A1 (ru) * 2005-10-31 2008-10-30 Биолипокс Аб Триазолы, пригодные для лечения воспалений

Similar Documents

Publication Publication Date Title
EP2018377A4 (en) 2-PYRAZINONE DERIVATIVES FOR THE TREATMENT OF A DISEASE OR CONDITION IN WHICH THE INHIBITION OF HUMAN NEUTROPHILUS ELASTASE HAS A BENEFIT EFFECT
EP2639229A3 (en) Thiazole Derivative and use thereof as VAP-1 Inhibitor
NO20084502L (no) Tetrahydropyrrolopyrimidinedioner og deres anvendelse som humane neutrofil elastase inhibitorer
EA201101243A1 (ru) 3h-имидазо[4,5-c]пиридин-6-карбоксамиды в качестве противовоспалительных средств
HUE039731T2 (hu) l,3-difenilprop-2-én-l-on-származékok alkalmazása májbetegségek kezelésére
ECSP088902A (es) Derivados de pirazolo[3,4-d]-pirimidina utiles para tratar trastornos respiratorios
WO2009127822A3 (en) Bis-aryl compounds for use as medicaments
EP2034839A4 (en) TREATMENT OF NEURODEEGENERATIVE DISEASES BY INHIBITION OF HSP90
CN102036649A8 (zh) 精氨酸盐及其治疗口腔疾病的用途
DE602007005120D1 (de) 2-pyridonderivate zur behandlung von krankheiten oder leiden, bei denen eine inhibierung der aktivität der neutrophilen elastase von nutzen ist
MX2010001020A (es) Derivados de pirimidina utiles para el tratamiento de condiciones inflamatorias o alergicas.
JP2007520565A5 (enExample)
ATE510536T1 (de) Verwendung von 2,5-dihydroxybenzol-derivaten zur behandlung von reaktiven gewebeerkrankungen
ZA200904975B (en) Use of chitosans for the treatment of nail inflammatory diseases
JP2008513426A5 (enExample)
FI20095600L (fi) Koostumus ihosairauksien hoitoa varten
FR2943537B1 (fr) Traitement des nevrites vestibulaires par l'acetyl-l-leucine
WO2007009720A3 (en) Prodrugs of pyrazoline compounds, their preparation and use as medicaments
NO20085028L (no) Substituerte karboksamider
PT1828151E (pt) Derivados de malonamida como inibidores de gama-secretase para o tratamento da doença de alzheimer
IL186022A0 (en) Dermatological compositions and salts for the treatment of dermatological diseases
JP2008513427A5 (enExample)
WO2007009721A3 (en) Indoline-substituted pyrazoline derivatives, their preparation and use as medicaments
EA200801107A1 (ru) Пиразолы, пригодные для лечения воспалений
WO2006108681A3 (en) Substances and pharmaceutical compositions for the inhibition of glyoxalases and their use against bacteria